Team leader, Avian viral disease team, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China (2021-present)
Professor, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China (2014-present)
Research Fellow, School of Biological Sciences, Nanyang Technological University, Singapore (2007-2009, 2010-2014)
Research Fellow, Institute of Molecular and Cell Biology, A*STAR, Singapore (2009-2010)
The general interest of my lab is to understand the virus life cycle, host anti-viral response, pathogenesis, and to develop the anti-viral therapeutics. In particularly, I focus on the research of coronavirus and paramyxovirus, including virus tropism, virus entry and uncoating, replication complex formation, viral protein translation, virion budding and release, ER stress response, mitochondria stress responses, innate immune responses, anti-viral therapy, vaccine development, etc. My research uses the SARS-CoV, infectious bronchitis virus (IBV), porcine coronavirus (PEDV), and the Newcastle disease virus (NDV) as model systems and employed multidisciplinary experimental approaches. We hope a detailed understanding of the intimate relationship between these individual viruses and the host-cell during infection will lead to the anti-viral drug and vaccine development. I also constructed the reverse genetic system of avian coronavirus, for the development of virus vector-based vaccine.
Team leader, Avian viral disease team, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China (2021-present)
Professor, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China (2014-present)
Research Fellow, School of Biological Sciences, Nanyang Technological University, Singapore (2007-2009, 2010-2014)
Research Fellow, Institute of Molecular and Cell Biology, A*STAR, Singapore (2009-2010)
The general interest of my lab is to understand the virus life cycle, host anti-viral response, pathogenesis, and to develop the anti-viral therapeutics. In particularly, I focus on the research of coronavirus and paramyxovirus, including virus tropism, virus entry and uncoating, replication complex formation, viral protein translation, virion budding and release, ER stress response, mitochondria stress responses, innate immune responses, anti-viral therapy, vaccine development, etc. My research uses the SARS-CoV, infectious bronchitis virus (IBV), porcine coronavirus (PEDV), and the Newcastle disease virus (NDV) as model systems and employed multidisciplinary experimental approaches. We hope a detailed understanding of the intimate relationship between these individual viruses and the host-cell during infection will lead to the anti-viral drug and vaccine development. I also constructed the reverse genetic system of avian coronavirus, for the development of virus vector-based vaccine.